Internal Medicine, Hematology & Oncology · Rehoboth Beach, DE
NPI
1790947174
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
18947 John J Williams Hwy
Rehoboth Beach, DE, 19971
Phone (302) 645-3770
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.5M
274,267 services
Medicare patients, 2024
967
Average age 74
Drug cost, 2024
$2.8M
1,087 prescriptions
Company payments, 2025
$1,292
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nouman Asif was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 57,780 times for 73 patients. In total Nouman Asif billed 274,267 services in 185 codes, and Medicare paid $5.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-12-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 57,780 | 73 | $2.27 | $131K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 14,200 | 20 | $44.67 | $634K |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 10,710 | 12 | $0.28 | $2,977 |
| J0897 Injection, denosumab, 1 mg | Office | 8,520 | 79 | $19.92 | $170K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 8,190 | 14 | $37.32 | $306K |
| J1756 Injection, iron sucrose, 1 mg | Office | 5,900 | 13 | $0.15 | $860 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 5,800 | 49 | $15.64 | $91K |
| 85025 Blood Count | Office | 2,707 | 561 | $7.58 | $21K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,030 | 35 | $0.09 | $183 |
| 80053 Clinical Chemistry | Office | 1,489 | 417 | $10.33 | $15K |
| 99213 Office E&M - Established | Office | 954 | 567 | $65.62 | $63K |
| 96372 Injection Administration | Office | 795 | 203 | $10.63 | $8,452 |
| 88185 Surgical Pathology Examination | Office | 774 | 26 | $21.45 | $17K |
| 83540 Clinical Chemistry | Office | 753 | 286 | $6.33 | $4,766 |
| 82728 Clinical Chemistry | Office | 752 | 286 | $13.34 | $10K |
By year: 2022 $4.3M for 450,011 services; 2023 $5.3M for 306,929 services; 2024 $5.5M for 274,267 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,707 | 561 | $7.58 | $21K |
| 80053 Clinical Chemistry | 1,489 | 417 | $10.33 | $15K |
| 88185 Surgical Pathology Examination | 774 | 26 | $21.45 | $17K |
| 83540 Clinical Chemistry | 753 | 286 | $6.33 | $4,766 |
| 82728 Clinical Chemistry | 752 | 286 | $13.34 | $10K |
| 83550 Clinical Chemistry | 751 | 286 | $8.56 | $6,426 |
| 82784 Immunoassay | 501 | 104 | $9.08 | $4,549 |
| 36415 Venipuncture Blood Collection | 429 | 246 | $8.65 | $3,711 |
| 83615 Clinical Chemistry | 163 | 115 | $5.90 | $961 |
| 83520 Immunoassay | 156 | 95 | $16.85 | $2,629 |
Medicare prescription drug claims, 2024
In 2024, the drug Nouman Asif prescribed most often to Medicare patients was Eliquis (Apixaban), with 125 prescriptions and refills. In total Nouman Asif wrote 1,087 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 125 | 157 | 34 | $87K |
| Xarelto Rivaroxaban | 109 | 196 | 23 | $106K |
| Anastrozole Generic | 74 | 213 | 23 | $2,013 |
| Letrozole Generic | 67 | 166 | 18 | $1,972 |
| Potassium Chloride Generic | 45 | 47 | 21 | $119 |
| Acyclovir Generic | 37 | 60 | Under 11 | $268 |
| Hydroxyurea Generic | 32 | 69 | Under 11 | $849 |
| Gabapentin Generic | 28 | 28 | Under 11 | $400 |
| Dexamethasone Generic | 26 | 28 | 12 | $275 |
| Prednisone Generic | 24 | 30 | Under 11 | $87.13 |
| Ondansetron Hcl Generic | 24 | 24 | 13 | $187 |
| Xtandi Enzalutamide | 23 | 23 | Under 11 | $325K |
| Brukinsa Zanubrutinib | 22 | 22 | Under 11 | $343K |
| Alendronate Sodium Generic | 22 | 56 | Under 11 | $278 |
| Calquence Acalabrutinib Maleate | 21 | 21 | Under 11 | $324K |
Brand drugs: 392 claims; generic drugs: 695 claims; opioid claims: 42.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nouman Asif $1,292 ($1,292 in general payments such as food, travel and fees) from 24 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $222.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 9 | $222 |
| Janssen Biotech, Inc. JNJ | 8 | $169 |
| Abbvie Inc. ABBV | 6 | $158 |
| Merck Sharp & Dohme LLC MRK | 3 | $90.57 |
| GlaxoSmithKline, LLC. GSK | 3 | $73.94 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $67.43 |
| Pfizer Inc. PFE | 2 | $63.8 |
| Genzyme Corporation SNY | 2 | $53.94 |
| Genentech USA, Inc. ROG.SW | 2 | $51.66 |
| Aveo Pharmaceuticals, Inc. | 1 | $29.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.